| 1 (269) | Novartis Institutes for Biomedical Research, Switzerland | CHE |  |
| 2 (317) | Hoffmann-La Roche, GmbH., Germany | DEU | |
| 3 (318) | Philips Research, Eindhoven | NLD | |
| 4 (339) | Roche Products Ltd, United Kingdom | GBR | |
| 5 (357) | AstraZeneca, United Kingdom | GBR | |
| 6 (430) | Hoffmann-La Roche Ltd, Switzerland | CHE | |
| 7 (479) | Novo Nordisk A/S | DNK | |
| 8 (524) | Sanofi, France | FRA | |
| 9 (558) | Janssen Research & Development, LLC | BEL | |
| 10 (588) | AstraZeneca, Sweden | SWE | |
| 11 (621) | Merck KGaA, Germany | DEU | |
| 12 (633) | Danone Nederland BV | NLD | |
| 13 (717) | Siemens AG, Germany | DEU | |
| 14 (734) | Bayer AG, Germany | DEU | |
| 15 (830) | Nestle Switzerland | CHE | |
| 16 (868) | Pfizer Inc, Spain | ESP | |
| 17 (876) | VTT Technical Research Centre of Finland | FIN | |
| 18 (878) | Boehringer Ingelheim GmbH Germany | DEU | |
| 19 (920) | Siemens Healthineers, Germany | DEU | |
| 20 (944) | IMEC International | BEL | |
| 21 (949) | Novartis, Switzerland | CHE | |
| 22 (991) | UCB Pharma SA, Belgium | BEL | |
| 23 (1004) | GlaxoSmithKline, United Kingdom | GBR | |
| 24 (1040) | Hypertension Arterielle, Pulmonaire: Physiopathologie et Innovation Therapeutique | FRA | |
| 25 (1108) | GlaxoSmithKline, Belgium | BEL | |
| 26 (1557) | BASF, Germany | DEU | |
| 27 (1731) | Bosch, Germany | DEU | |
| 28 (1983) | Pfizer Inc, United Kingdom | GBR | |
| 29 (2473) | SINTEF Group * | NOR | |
| 30 (4802) | Grupo Jose de Mello * | PRT | |
| 31 (5074) | IQVIA, Germany | DEU | |
|
